Patient info Open main menu

Lopinavir / Ritonavir Accord 200 mg / 50 mg film-coated tablets - Patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
200 mg / 50 mg
Contains active substances:

Patient leaflet - Lopinavir / Ritonavir Accord 200 mg / 50 mg film-coated tablets

1. What Lopinavir/Ritonavir tablets are and what they are used for

  • Your doctor has prescribed Lopinavir/Ritonavir tablets to help to control your Human Immunodeficiency Virus (HIV) infection. Lopinavir/Ritonavir tablets does this by slowing down the spread of the infection in your body.
  • Lopinavir/Ritonavir tablets is not a cure for HIV infection or AIDS.
  • Lopinavir/Ritonavir tablets is used by children 2 years of age or older, adolescents and adults who are infected with HIV, the virus which causes AIDS.
  • Lopinavir/Ritonavir tablets contains the active substances lopinavir and ritonavir. Lopinavir/Ritonavir tablets is an antiretroviral medicine. It belongs to a group of medicines called protease inhibitors.
  • Lopinavir/Ritonavir tablets is prescribed for use in combination with other antiviral medicines. Your doctor will discuss with you and determine which medicines are best for you.

2. What you need to know before you or your child take Lopinavir/Ritonavir tablets

Do not take Lopinavir/Ritonavir tablets

  • if you are allergic to lopinavir, ritonavir or any of the other ingredients of this medicine (listed in section 6)
  • if you have severe liver problems.

Do not take Lopinavir/Ritonavir tablets with any of the following medicines:

  • Astemizole or terfenadine (commonly used to treat allergy symptoms – these medicines may be available without prescription);
  • Midazolam taken orally (taken by mouth), triazolam (used to relieve anxiety and/or trouble sleeping);
  • Pimozide (used to treat schizophrenia);
  • Quetiapine (used to treat schizophrenia, bipolar disorder and major depressive disorder);
  • Lurasidone (used to treat depression);
  • Ranolazine (used to treat chronic chest pain [angina]);
  • Cisapride (used to relieve certain stomach problems);
  • Ergotamine, dihydroergotamine, ergonovine, methylergonovine (used to treat headaches);
  • Amiodarone, dronedarone (used to treat abnormal heart beat);
  • Lovastatin, simvastatin (used to lower blood cholesterol);
  • Lomitapide (used to lower blood cholesterol);
  • Alfuzosin (used in men to treat symptoms of an enlarged prostate (benign prostatic hyperplasia (BPH));
  • Fusidic acid (used to treat skin infections caused by Staphylococcus bacteria such as impetigo and infected dermatitis. Fusidic acid used to treat long-term infections of the bones and joints may be taken under doctor’s supervision (see Other medicines and Lopinavir/Ritonavir tablets);
  • Colchicine (used to treat gout) if you have kidney and/or liver problems (see Other medicines and Lopinavir/Ritonavir tablets);
  • elbasvir/grazoprevir (used to treat chronic hepatitis C virus [HCV]);
  • Neratinib (used to treat breast cancer);
  • Avanafil or vardenafil (used to treat erectile dysfunction);
  • Sildenafil used to treat pulmonary arterial hypertension (high blood pressure in the pulmonary artery). Sildenafil used to treat erectile dysfunction may be taken under doctor’s supervision (see Other medicines and Lopinavir/Ritonavir tablets);
  • Products that contain St John’s wort (Hypericum perforatum).

Read the list of medicines below under ‘Other medicines and

Lopinavir/Ritonavir tablets’ for information on certain other medicines which require special care.

If you are currently taking any of these medicines, ask your doctor about making necessary changes either in the treatment for your other condition(s) or in your antiretroviral treatment.

Warnings and precautions

Talk to your doctor or pharmacist before taking Lopinavir/Ritonavir tablets.

Important information

  • People taking Lopinavir/Ritonavir tablets may still develop infections or other illnesses associated with HIV disease and AIDS. It is therefore important that you remain under the supervision of your doctor while taking Lopinavir/Ritonavir tablets.

Tell your doctor if you or your child have/had:

  • Haemophilia type A and B as Lopinavir/Ritonavir tablets might increase the risk of bleeding.
  • Diabetes as increased blood sugars has been reported in patients receiving lopinavir/ritonavir.
  • A history of liver problems as patients with a history of liver disease, including chronic hepatitis B or C are at increased risk of severe and potentially fatal liver side effects.

Tell your doctor if you or your child experience:

  • Nausea, vomiting, abdominal pain, difficulty breathing and severe weakness of the muscles in the legs and arms as these symptoms may indicate raised lactic acid levels.
  • Thirst, frequent urination, blurred vision or weight loss as this may indicate raised sugar levels in the blood.
  • Nausea, vomiting, abdominal pain as large increases in the amount of triglycerides (fats in the blood) have been considered a risk factor for pancreatitis (inflammation of the pancreas) and these symptoms may suggest this condition.
  • In some patients with advanced HIV infection and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. It is believed that these symptoms are due to an improvement in the body’s immune response, enabling the body to fight infections that may have been present with no obvious symptoms.

    In addition to the opportunistic infections, autoimmune disorders (a condition that occurs when the immune system attacks healthy body tissue) may also occur after you start taking medicines for the treatment of your HIV infection. Autoimmune disorders may occur many months after the start of treatment. If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivity, please inform your doctor immediately to seek necessary treatment.

  • Joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement as some patients taking these medicines may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone). The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression (reduction in the activity of the immune system), higher body mass index, among others, may be some of the many risk factors for developing this disease.
  • Muscle pain, tenderness or weakness, particularly in combination with these medicines. On rare occasions these muscle disorders have been serious.
  • Symptoms of dizziness, lightheadedness, fainting or sensation of abnormal heartbeats. Lopinavir/Ritonavir tablets may cause changes in your heart rhythm and the electrical activity of your heart. These changes may be seen on an ECG (electrocardiogram).

Other medicines and Lopinavir/Ritonavir tablets

Tell your doctor or pharmacist if you or your child are taking, have recently taken or might take any other medicines.

  • Antibiotics (e.g. rifabutin, rifampicin, clarithromycin);
  • Anticancer medicines (e.g. abemaciclib, afatinib, apalutamide, ceritinib, encorafenib, ibrutinib, venetoclax, most tyrosine kinases inhibitors such as dasatinib and nilotinib, also vincristine and vinblastine);
  • Anticoagulants (e.g. dabigatran etexilate, edoxaban, rivaroxaban and warfarin);
  • Antidepressants (e.g. trazodone, bupropion);
  • Anti-epilepsy medicines (e.g. carbamazepine, phenytoin, phenobarbital, lamotrigine and valproate);
  • Antifungals (e.g. ketoconazole, itraconazole, voriconazole);
  • Anti-gout medicines (e.g. colchicine). You must not take Lopinavir/Ritonavir tablets with colchicine if you have kidney and/or liver problems (see also ‘Do not take Lopinavir/Ritonavir tablets’ above);
  • anti-tuberculosis medicine (bedaquiline, delamanid)
  • Antiviral medicine used to treat chronic hepatitis C virus (HCV) infection in adults (e.g. glecaprevir/pibrentasvir, simeprevir and sofosbuvir/velpatasvir/voxilaprevir);
  • Erectile dysfunction medicines (e.g. sildenafil and tadalafil);
  • Fusidic acid used to treat long-term infections of the bones and joints (e.g. osteomyelitis);
  • Heart medicines including:

    • Digoxin;
    • Calcium channel antagonists (e.g. felodipine, nifedipine, nicardipine);
    • Medicines used to correct heart rhythm (e.g. bepridil, systemic

      lidocaine, quinidine);

  • HIV CCR5-antagonist (e.g. maraviroc);
  • HIV-1 integrase inhibitor (e.g. raltegravir);
  • Medicines used to treat low blood platelet count (e.g. fostamatinib);
  • levothyroxine (used to treat thyroid problems);
  • Medicines used to lower blood cholesterol (e.g. atorvastatin, lovastatin, rosuvastatin or simvastatin);
  • Medicines used to treat asthma and other lung-related problems such as chronic obstructive pulmonary disease (COPD) (e.g. salmeterol);
  • Medicines used to treat pulmonary arterial hypertension (high blood pressure in the pulmonary artery) (e.g. bosentan, riociguat, sildenafil, tadalafil);
  • Medicines affecting the immune system (e.g. cyclosporin, sirolimus (rapamycin), tacrolimus);
  • Medicines used for smoking cessation (e.g. bupropion);
  • Pain-relieving medicines (e.g. fentanyl);
  • Morphine-like medicines (e.g. methadone);

    • Non-nucleoside reverse transcriptase inhibitors (NNRTIs) (e.g. efavirenz, nevirapine);
    • Oral contraceptive or using a patch contraceptive to prevent pregnancy (see section below titled Contraceptives);
    • Protease inhibitors (e.g. fosamprenavir, ritonavir, tipranavir);
    • Sedatives (e.g. midazolam administered by injection);
    • Steroids (e.g. budesonide, dexamethasone, fluticasone propionate, ethinyl oestradiol, triamcinolone).

Read the list of medicines above ‘Do not take Lopinavir/Ritonavir tablets with any of the following medicines’ for information on medicines that you must not take with Lopinavir/Ritonavir tablets.

Tell your doctor or pharmacist if you or your child are taking, have recently taken or might take any other medicines, including medicines obtained without prescription.

Erectile dysfunction medicines (avanafil, vardenafil, sildenafil, tadalafil)

  • Do not take Lopinavir/Ritonavir tablets if you are currently taking avanafil or vardenafil.
  • You must not take Lopinavir/Ritonavir tablets with sildenafil used to treat pulmonary arterial hypertension (high blood pressure in the pulmonary artery) (see also Do not take Lopinavir/Ritonavir tablets section above).
  • If you take sildenafil or tadalafil and Lopinavir/Ritonavir tablets together, you may be at risk of side effects such as low blood pressure, passing out, visual changes and penile erection lasting more than 4 hours. If an erection lasts longer than 4 hours, you should get medical help immediately to avoid permanent damage to your penis. Your doctor can explain these symptoms to you.

Contraceptives

  • If you are currently using an oral contraceptive or using a patch contraceptive to prevent pregnancy, you should use an additional or different type of contraception (e.g. condom) as Lopinavir/Ritonavir tablets may reduce the effectiveness of oral and patch contraceptives.

Pregnancy and breast-feeding

  • Tell your doctor immediately if you are planning to have a baby, you are pregnant or think you may be pregnant.
  • If you are breast-feeding, or thinking about breast-feeding, you should discuss it with your doctor as soon as possible.
  • It is recommended that women living with HIV do not breast-feed their infants because there is a possibility that the baby can be infected with HIV through your breast milk.

Driving or using machines

Lopinavir/Ritonavir tablets has not specifically been tested for its possible effects on the ability to drive a car or operate machines. Do not drive a car or operate machinery if you experience any side effects (e.g. nausea) that impact your ability to do so safely. Instead, contact your doctor.

Information on sodium content

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium free’.

3. How to take Lopinavir/Ritonavir tablets

It is important that Lopinavir/Ritonavir tablets are swallowed whole and not chewed, broken or crushed.

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure how you should take your medicine.

How much Lopinavir/Ritonavir tablets should be taken and when?

Use in adults

  • The usual adult dose is 400 mg/100 mg twice a day i.e. every 12 hours, in combination with other anti-HIV medicines. Adult patients who have not previously taken other antiviral medicines can also take Lopinavir/Ritonavir tablets once daily as an 800 mg/200 mg dose. Your doctor will advise on the number of tablets to be taken. Adult patients who have previously taken other antiviral medicines can take Lopinavir/Ritonavir tablets once daily as an 800 mg/200 mg dose if their doctor decides it is appropriate.
  • Lopinavir/Ritonavir tablets must not be taken once daily with efavirenz, nevirapine, carbamazepine, phenobarbital and phenytoin.
  • Lopinavir/Ritonavir tablets can be taken with or without food.

Use in children

  • For children, your doctor will decide the right dose (number of tablets) based on the child’s height and weight.
  • Lopinavir/Ritonavir tablets can be taken with or without food.

If you or your child take more Lopinavir/Ritonavir tablets than you should

  • If you realise you have taken more Lopinavir/Ritonavir tablets than you were supposed to, contact your doctor right away.
  • If you cannot contact your doctor, go to the hospital.

If you or your child forget to take Lopinavir/Ritonavir tablets

If you are taking Lopinavir/Ritonavir tablets twice a day

  • If you notice you miss a dose within 6 hours of your normal dosing time, take your missed dose as soon as possible, and then continue with your normal dose at the regular time as prescribed by your doctor.
  • If you notice you miss a dose by more than 6 hours after your normal dosing time, do not take the missed dose. Take the next dose as usual. Do not take a double dose to make up for a forgotten dose.

\\PIT-O-0084\Sharing data\Mockup - SandipData\ACCORD MOCK UP AWS\Lopinavir-Ritonavir\01_UK-MT\UK

Front Side Page

\\PIT-O-0084\Sharing data\Mockup - SandipData\ACCORD MOCK UP AWS\Lopinavir-Ritonavir\01_UK-MT\UK

Back Side Page

If you are taking Lopinavir/Ritonavir tablets once a day

  • If you notice you miss a dose within 12 hours of your normal dosing time, take your missed dose as soon as possible, and then continue with your normal dose at the regular time as prescribed by your doctor.
  • If you notice you miss a dose by more than 12 hours after your normal dosing time, do not take the missed dose. Take the next dose as usual. Do not take a double dose to make up for a forgotten dose.

If you or your child stop taking Lopinavir/Ritonavir tablets

  • Do not stop or change the daily dose of Lopinavir/Ritonavir tablets without first consulting with your doctor.
  • Lopinavir/Ritonavir tablets should always be taken every day to help control your HIV infection, no matter how much better you feel.
  • Taking Lopinavir/Ritonavir tablets as recommended should give you the best chance of delaying the development of resistance to the product.
  • If a side effect is preventing you from taking Lopinavir/Ritonavir tablets as directed tell your doctor right away.
  • Always keep enough Lopinavir/Ritonavir tablets on hand so you don’t run out. When you travel or need to stay in the hospital make sure you will have enough Lopinavir/Ritonavir tablets to last until you can get a new supply.
  • Continue to take this medicine until your doctor tells you otherwise.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. It may be difficult to tell which side effects have been caused by Lopinavir/Ritonavir tablets and which may occur due to other medicines you take at the same time or by the complications of the HIV infection.

During HIV therapy there may be an increase in weight and in levels of blood lipids and glucose. This is partly linked to restored health and life style, and in the case of blood lipids sometimes to the HIV medicines themselves. Your doctor will test for these changes.

The following side effects have been reported by patients who took this medicine. You should tell your doctor promptly about these or any other symptoms. If the condition persists or worsens, seek medical attention.

Very Common: may affect more than 1 in 10 people

  • Diarrhoea;
  • Nausea;
  • Upper respiratory tract infection.

Common: may affect up to 1 in 10 people

  • Inflammation of the pancreas;
  • Vomiting, enlarged abdomen, pain in the lower and upper stomach area, passing wind, indigestion, decreased appetite, reflux from your stomach to your oesophagus which may cause pain;

    • Tell your doctor if you experience nausea, vomiting or abdominal

      pain as these may be suggestive of pancreatitis (inflammation of the pancreas).

  • Swelling or inflammation of the stomach, intestines and colon;
  • Increased cholesterol levels in your blood, increased triglycerides (a form of fat) levels in your blood, high blood pressure;
  • Decreased ability of the body to handle sugar including diabetes mellitus, weight loss;
  • Low number of red blood cells, low number of white blood cells which are usually used to fight infection;
  • Rash, eczema, accumulation of scales of greasy skin;
  • Dizziness, anxiety, difficulty in sleeping;
  • Feeling tired, lack of strength and energy, headache including migraine;
  • Haemorrhoids;
  • Inflammation of the liver including increased liver enzymes;
  • Allergic reactions including hives and inflammation in the mouth;
  • Lower respiratory tract infection;
  • Enlargement of the lymph nodes;
  • Impotence, abnormally heavy or extended menstrual flow or a lack of menstruation;
  • Muscle disorders such as weakness and spasms, pain in the joints, muscles and back;
  • Damage to nerves of the peripheral nervous system;
  • Night sweats, itching, rash including raised bumps on the skin, infection of the skin, inflammation of skin or hair pores, accumulation of fluid in the cells or tissues.

Uncommon: may affect up to 1 in 100 people

  • Abnormal dreams;
  • Loss or changed sense of taste;
  • Hair loss;
  • An abnormality in your electrocardiogram (ECG) called atrioventricular block;
  • Plaque building up inside your arteries which could lead to heart attack and stroke;
  • Inflammation of blood vessels and capillaries;
  • Inflammation of the bile duct;
  • Uncontrolled shaking of the body;
  • Constipation;
  • Deep vein inflammation related to a blood clot;
  • Dry mouth;
  • Inability to control your bowels;
  • Inflammation of the first section of the small intestine just after the stomach, wound or ulcer in the digestive tract, bleeding from the intestinal tract or rectum;
  • Red blood cells in the urine;
  • Yellowing of the skin or whites of eyes (jaundice);
  • Fatty deposits in the liver, enlarged liver;
  • Lack of functioning of the testes;

    • A flare-up of symptoms related to an inactive infection in your body (immune reconstitution);
    • Increased appetite;
    • Abnormally high level of bilirubin (a pigment produced from the breakdown of red blood cells) in the blood
    • Decreased sexual desire;
    • Inflammation of the kidney;
    • Bone death caused by poor blood supply to the area;
    • Mouth sores or ulcerations, inflammation of the stomach and intestine;
    • Kidney failure;
    • Breakdown of muscle fibers resulting in the release of muscle fiber contents (myoglobin) into the bloodstream;
    • A sound in one ear or both ears, such as buzzing, ringing or whistling;
    • Tremor;
    • Abnormal closure of one of the valves (tricuspid valve in your heart);
    • Vertigo (spinning feeling);
    • Eye disorder, abnormal vision;
    • Weight gain.

Rare: may affect up to 1 in 1 000 people

  • severe or life-threatening skin rashes and blisters (Stevens-Johnson syndrome and erythema multiforme).

Not known: frequency cannot be estimated from the available data

  • kidney stones.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please inform your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Lopinavir/Ritonavir tablets

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the pack.
  • This medicinal product does not require any special storage conditions.
  • Do not use this medicine if you notice any discolouration.

How should I dispose of any unused Lopinavir/Ritonavir tablets?

  • Do not throw away any medicines via wastewater.
  • Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Lopinavir/Ritonavir tablets contain

The active substances are lopinavir and ritonavir.

Each tablet of Lopinavir/Ritonavir tablets contains 200 mg of lopinavir and 50 mg of ritonavir.

The other ingredients are:

Tablet: Copovidone, sorbitan laurate, colloidal anhydrous silica, sodium stearyl fumarate.

Tablet coating: Hypromellose (E464), titanium dioxide (E171), macrogol (polyethylene glycol 400), hydroxypropyl cellulose (E463), talc (E553b), colloidal anhydrous silica (E551), macrogol (polyethylene glycol 3350), yellow ferric oxide (E172), polysorbate 80 (E433).

What Lopinavir/Ritonavir tablets look like and contents of the pack

Lopinavir/Ritonavir tablets are yellow, oval, biconvex, film-coated tablets, with a dimension of approx. 19.0 mm in length and 10.2 mm in width, debossed with “H” on one side and “L3” on other side.

Lopinavir/Ritonavir film-coated tablets are supplied in packs of 120 tablets (1 plastic bottle of 120 tablets) and 360 tablets (3 plastic bottles of 120 tablets). Blister multipacks containing 60 and 120 tablets (1 pack of 120 tablets or 3 packs of 40 tablets) are also available.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Accord Healthcare Limited

Sage House, 319, Pinner Road, North Harrow

Middlesex, HA1 4HF

United Kingdom

Manufacturer

Accord Healthcare Limited

Sage House, 319, Pinner Road, North Harrow

Middlesex, HA1 4HF

United Kingdom

Pharmadox Healthcare, Ltd.

KW20A Kordin Industrial Park,

Paola, PLA 3000, Malta

This leaflet was last revised in 06/2026.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20075/0527

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lopinavir / Ritonavir Accord 200 mg / 50 mg film-coated tablets

Active substances Ritonavir, Lopinavir
Strength 200 mg / 50 mg
Pharmaceutical form Oral tablet
Lopinavir / Ritonavir tablets are yellow, oval, biconvex, film-coated tablets, with a dimension of approx. 19.0 mm in length and 10.2 mm in width, debossed with “H” on one side and “L3” on other side.
How is it taken Oral
Excipients Copovidone, Sorbitanlaurate, Colloidal anhydrous silica, Sodium stearyl fumarate, Hypromellose (E464), Titanium dioxide (E171), Macrogol (Polyethylene glycol 400), Hydroxypropyl cellulose (E463), Talc (E553b), Colloidal anhydrous silica (E551), Macrogol (Polyethylene glycol 3350), Yellow ferric oxide (E172), Polysorbate 80 (E433)
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life HDPE bottles and PVC/PVDC-Al blisters: 2 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AR Antivirals for treatment of HIV infections, combinations
          1. J05AR10 lopinavir and ritonavir
Marketing authorisation PL 20075/0527 (first authorised 31 March 2022)
Marketing authorisation holder Accord Healthcare Limited
Codes BNF 05030100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.